IGF status is altered by tamoxifen in patients with breast cancer
Data(s) |
2001
|
---|---|
Resumo |
Aims-An increased concentration of insulin-like growth factor 1 (IGF-1) is an independent risk factor for premenopausal breast cancer. Tamoxifen is thought initially to reduce concentrations of IGF-1 and increase concentrations of the IGF binding proteins. The aim of this study was to compare concentrations of IGF-1, IGF binding protein 1 (IGF-BP1), and IGF-BP3 in patients with breast cancer (n = 14) with those seen in control subjects (n = 23) and to assess the effect of tamoxifen on IGF status in these patients. |
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Campbell , M , Woodside , J , Secker-Walker , J , Titcomb , A & Leathem , C 2001 , ' IGF status is altered by tamoxifen in patients with breast cancer ' JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY , vol 54 , no. 5 , pp. 307-310 . |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2734 #Pathology and Forensic Medicine |
Tipo |
article |